Blueshift Asset Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.66 - $12.39 $74,338 - $138,297
11,162 New
11,162 $84,000
Q2 2022

Aug 12, 2022
SELL
$8.95 - $12.8 $232,359 - $332,313
-25,962 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$10.05 - $22.48 $260,918 - $583,625
25,962 New
25,962 $321,000
Q4 2020

Feb 12, 2021
SELL
$12.94 - $16.05 $129,956 - $161,190
-10,043 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$13.19 - $16.66 $132,467 - $167,316
10,043 New
10,043 $148,000

Others Institutions Holding AUPH

# of Institutions
210
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email